196 related articles for article (PubMed ID: 10220176)
1. Modulation of antibacterial peptide activity by products of Porphyromonas gingivalis and Prevotella spp.
Devine DA; Marsh PD; Percival RS; Rangarajan M; Curtis MA
Microbiology (Reading); 1999 Apr; 145 ( Pt 4)():965-971. PubMed ID: 10220176
[TBL] [Abstract][Full Text] [Related]
2. Killing of Fusobacterium nucleatum, Porphyromonas gingivalis and Prevotella intermedia by protegrins.
Miyasaki KT; Iofel R; Oren A; Huynh T; Lehrer RI
J Periodontal Res; 1998 Feb; 33(2):91-8. PubMed ID: 9553868
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial susceptibilities of Porphyromonas gingivalis, Prevotella intermedia, and Prevotella nigrescens spp. isolated in Spain.
Andrés MT; Chung WO; Roberts MC; Fierro JF
Antimicrob Agents Chemother; 1998 Nov; 42(11):3022-3. PubMed ID: 9797247
[TBL] [Abstract][Full Text] [Related]
4. Identification of a chromosomally encoded kanamycin acetylase in Porphyromonas gingivalis.
Kato T; Hirai K; Okuda K
FEMS Microbiol Lett; 1995 Sep; 131(3):301-6. PubMed ID: 7557341
[TBL] [Abstract][Full Text] [Related]
5. The effects of magainin 2, cecropin, mastoparan and melittin on Brucella abortus.
Halling SM
Vet Microbiol; 1996 Jul; 51(1-2):187-92. PubMed ID: 8828135
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the antimicrobial effect of lactoferrin on Porphyromonas gingivalis, Prevotella intermedia and Prevotella nigrescens.
Aguilera O; Andrés MT; Heath J; Fierro JF; Douglas CW
FEMS Immunol Med Microbiol; 1998 May; 21(1):29-36. PubMed ID: 9657318
[TBL] [Abstract][Full Text] [Related]
7. Dipeptide utilization by the periodontal pathogens Porphyromonas gingivalis, Prevotella intermedia, Prevotella nigrescens and Fusobacterium nucleatum.
Takahashi N; Sato T
Oral Microbiol Immunol; 2002 Feb; 17(1):50-4. PubMed ID: 11860556
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of macrocarpals on the biological activity of Porphyromonas gingivalis and other periodontopathic bacteria.
Nagata H; Inagaki Y; Yamamoto Y; Maeda K; Kataoka K; Osawa K; Shizukuishi S
Oral Microbiol Immunol; 2006 Jun; 21(3):159-63. PubMed ID: 16626372
[TBL] [Abstract][Full Text] [Related]
9. In vitro anti‑bacterial activity of diosgenin on Porphyromonas gingivalis and Prevotella intermedia.
Cong S; Tong Q; Peng Q; Shen T; Zhu X; Xu Y; Qi S
Mol Med Rep; 2020 Dec; 22(6):5392-5398. PubMed ID: 33174005
[TBL] [Abstract][Full Text] [Related]
10. Susceptibilities of Bordetella pertussis strains to antimicrobial peptides.
Fernandez RC; Weiss AA
Antimicrob Agents Chemother; 1996 Apr; 40(4):1041-3. PubMed ID: 8849226
[TBL] [Abstract][Full Text] [Related]
11. An investigation into the use of SDS-PAGE of cell surface extracts and proteolytic activity to differentiate Prevotella nigrescens and Prevotella intermedia.
Cookson AL; Wray A; Handley PS; Jacob AE
FEMS Microbiol Lett; 1996 Feb; 136(2):109-15. PubMed ID: 8869494
[TBL] [Abstract][Full Text] [Related]
12. Sensitivity of genera Porphyromonas and Prevotella to the bactericidal action of C-terminal domain of human CAP18 and its analogues.
Isogai E; Isogai H; Matuo K; Hirose K; Kowashi Y; Okumuara K; Hirata M
Oral Microbiol Immunol; 2003 Oct; 18(5):329-32. PubMed ID: 12930528
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial activity of magainin analogues against anaerobic oral pathogens.
Genco CA; Maloy WL; Kari UP; Motley M
Int J Antimicrob Agents; 2003 Jan; 21(1):75-8. PubMed ID: 12507842
[TBL] [Abstract][Full Text] [Related]
14. Structure-antibacterial, antitumor and hemolytic activity relationships of cecropin A-magainin 2 and cecropin A-melittin hybrid peptides.
Shin SY; Kang JH; Hahm KS
J Pept Res; 1999 Jan; 53(1):82-90. PubMed ID: 10195445
[TBL] [Abstract][Full Text] [Related]
15. In vitro Resistance Testing of Porphyromonas gingivalis, Prevotella intermedia, and Tannerella forsythia to Triclosan.
Farsi D; Tanner A
J Contemp Dent Pract; 2016 Apr; 17(4):282-5. PubMed ID: 27340161
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-1alpha stimulation in monocytes by periodontal bacteria: antagonistic effects of Porphyromonas gingivalis.
Bostanci N; Allaker R; Johansson U; Rangarajan M; Curtis MA; Hughes FJ; McKay IJ
Oral Microbiol Immunol; 2007 Feb; 22(1):52-60. PubMed ID: 17241171
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial and immunomodulatory properties of PGLa-AM1, CPF-AM1, and magainin-AM1: potent activity against oral pathogens.
McLean DT; McCrudden MT; Linden GJ; Irwin CR; Conlon JM; Lundy FT
Regul Pept; 2014 Nov; 194-195():63-8. PubMed ID: 25447193
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial activity of silver nitrate against periodontal pathogens.
Spacciapoli P; Buxton D; Rothstein D; Friden P
J Periodontal Res; 2001 Apr; 36(2):108-13. PubMed ID: 11327077
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of lactoferrin on growth and biofilm formation of Porphyromonas gingivalis and Prevotella intermedia.
Wakabayashi H; Yamauchi K; Kobayashi T; Yaeshima T; Iwatsuki K; Yoshie H
Antimicrob Agents Chemother; 2009 Aug; 53(8):3308-16. PubMed ID: 19451301
[TBL] [Abstract][Full Text] [Related]
20. Cecropin A - magainin 2 hybrid peptides having potent antimicrobial activity with low hemolytic effect.
Shin SY; Kang JH; Lee MK; Kim SY; Kim Y; Hahm KS
Biochem Mol Biol Int; 1998 May; 44(6):1119-26. PubMed ID: 9623765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
